TW201436822A - Panax notoginseng broken wall preparation - Google Patents

Panax notoginseng broken wall preparation Download PDF

Info

Publication number
TW201436822A
TW201436822A TW103110366A TW103110366A TW201436822A TW 201436822 A TW201436822 A TW 201436822A TW 103110366 A TW103110366 A TW 103110366A TW 103110366 A TW103110366 A TW 103110366A TW 201436822 A TW201436822 A TW 201436822A
Authority
TW
Taiwan
Prior art keywords
ethanol
sanqi
ultrafine powder
ratio
broken wall
Prior art date
Application number
TW103110366A
Other languages
Chinese (zh)
Other versions
TWI549700B (en
Inventor
jin-le Cheng
Yong-Jun Chen
guan-feng Su
jin-mei Chen
Yu-Tang Chen
Original Assignee
Zhongshan zhongzhi pharmaceutical group co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongshan zhongzhi pharmaceutical group co ltd filed Critical Zhongshan zhongzhi pharmaceutical group co ltd
Publication of TW201436822A publication Critical patent/TW201436822A/en
Application granted granted Critical
Publication of TWI549700B publication Critical patent/TWI549700B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a traditional Chinese herbal preparation. In particular, the present invention relates to a Panax notoginseng broken wall preparation, of which the preparation is produced by pulverizing powder of Panax notoginseng into ultrafine powder, further by ethanol - wet granulation, extrusion at a certain speed, and dried. The resulting preparation with broken wall of Panax notoginseng has higher bioavailability rate, stable preparation, and good disintegration.

Description

一種三七破壁製劑 Sanqi broken wall preparation

本發明係關於中醫藥領域,更具體地,係關於一種三七破壁製劑。 The present invention relates to the field of traditional Chinese medicine, and more particularly to a Sanqi broken wall preparation.

超微粉碎技術是近年來迅速發展的一項新技術。中藥材中的有效成分大多分佈在細胞內,常規飲片煎煮時只能使部分有效成分釋放出來,有效成分利用率10-30%;而採用破壁粉碎技術,如將中藥飲片粉碎至300目左右,細胞破壁率將達到86.7%,提高了藥材中有效成分的溶出,大大增強其藥效,有效成分利用率在90%以上,達到減少藥材使用量及保護藥材資源,同時還可提高藥品的品質增加藥效。但是,目前的主要超微粉技術仍停留在將中藥材粉碎至超細製劑的階段。由於超細製劑細胞破壁率增加,存在破壁製劑表面積增大,形狀不規則,流動性、分散性差,易於吸濕,穩定性差等固有特點,將其製粒,提高產品的穩定性,本發明製備的製劑很好的解決了以上存在的問題,達到藥材的利用及使用最大化。 Superfine pulverization technology is a new technology that has developed rapidly in recent years. Most of the active ingredients in Chinese herbal medicines are distributed in the cells. When the conventional decoction pieces are boiled, only some of the active ingredients can be released, and the effective ingredient utilization rate is 10-30%; and the broken wall crushing technology, such as the Chinese medicine decoction pieces, is crushed to 300 mesh. Left and right, the cell wall breaking rate will reach 86.7%, which improves the dissolution of the active ingredients in the medicinal materials, greatly enhances its efficacy, and the utilization rate of the active ingredients is above 90%, thereby reducing the amount of medicinal materials used and protecting the medicinal materials, and also improving the medicines. The quality of the product increases the efficacy. However, the current main ultrafine powder technology still stays at the stage of pulverizing Chinese herbal medicines to ultrafine preparations. Due to the increased cell wall breaking rate of the ultrafine preparation, the surface area of the broken wall preparation is increased, the shape is irregular, the fluidity, the dispersibility is poor, the moisture absorption is easy, and the stability is poor, and the granulation is performed to improve the stability of the product. The preparation prepared by the invention solves the above problems well and maximizes the utilization and use of the medicine.

目前,對於破壁製劑及其製粒過程中存在以下的技術難題:(1)目前的破壁製劑儘管中藥成分的利用率高,但破壁粉體易於被氧化,穩定性不高,藥效容易喪失;(2)已有的中藥品種通過軟材製粒獲得的產品,很難同時保證收率、崩解性和穩定性;(3)有些中藥品種是不適宜採用破壁粉體-軟材製粒法製成製劑的,如枸杞、懷牛膝之類;而本發明通過 大量實驗性的摸索,將適宜破壁粉體-軟材製粒法的中藥品種篩選出來,並且摸索出各步驟的條件。 At present, the following technical problems exist in the broken wall preparation and its granulation process: (1) The current broken wall preparation is easy to be oxidized due to high utilization rate of traditional Chinese medicine ingredients, and the stability is not high, and the efficacy is low. It is easy to lose; (2) It is difficult to ensure the yield, disintegration and stability of the traditional Chinese medicine varieties obtained by soft material granulation; (3) Some Chinese medicine varieties are not suitable for using broken wall powder-soft Prepared by the granulation method, such as sputum, achyranthes, etc.; A large number of experimental explorations, screening the Chinese medicine varieties suitable for the broken wall powder-soft material granulation method, and exploring the conditions of each step.

三七為五加科植物三七Panax notoginseng(Burk.)F.H.Chen的乾燥根和根莖。其有效成分為四環三萜類成分:人參皂苷Rb1、Rd、Re、Rg1、Rg2、Rh1,三七皂苷R1、R2、R3、R5、R6、R7,七葉膽苷,三七皂苷A、B、C、D等;還含三七素,槲皮素及多糖等,採用傳統的煎煮方法,容易破壞其熱敏性成分,另一方面有效成分煎煮不完全,造成有效成分的流失。將三七製備成三七超細粉體,有利於提高有效成分的利用率,但同時由於粉體比表面積的增加,產生易於吸潮、氧化、變質等的缺點。因此,在製備成超細粉體的基礎上,還需要對其進行進一步的加工改造,以有效克服這些不利因素,最大化的發揮藥物的治療效果。 Panax notoginseng is the dried roots and rhizomes of the Panax notoginseng (Burk.) FHChen. The active ingredient is a tetracyclic triterpenoid component: ginsenoside Rb 1 , Rd, Re, Rg 1 , Rg 2 , Rh 1 , notoginsenoside R 1 , R 2 , R 3 , R 5 , R 6 , R 7 , Heptaphylline, notoginsenoside A, B, C, D, etc.; also contains notoginseng, quercetin and polysaccharides, etc., using traditional boiling methods, easy to destroy its heat-sensitive ingredients, on the other hand, active ingredients decoction Incomplete, resulting in the loss of active ingredients. The preparation of Panax notoginseng into a fine powder of Panax notoginseng is beneficial to increase the utilization rate of the active ingredient, but at the same time, due to the increase of the specific surface area of the powder, it has the disadvantages of easy moisture absorption, oxidation, deterioration and the like. Therefore, on the basis of preparation of ultrafine powder, it is necessary to further process and modify it to effectively overcome these unfavorable factors and maximize the therapeutic effect of the drug.

本發明所要解決的技術問題是,為了克服現有技術中三七破壁粉體的上述不足,提供一種三七破壁製劑。 The technical problem to be solved by the present invention is to provide a Sanqi broken wall preparation in order to overcome the above-mentioned deficiencies of the prior art Sanqi broken wall powder.

本發明所要解決的上述技術問題通過以下技術方案予以實現:本發明提供的一種三七破壁製劑,採用如下的技術方案:將三七進行破壁粉碎獲得超細粉體,加入乙醇-水溶液充分混合,製得軟材,再進一步擠壓獲得濕粒,乾燥獲得三七破壁製劑,該超細粉體的破壁率為80~95%;該超細粉體中90%或以上的顆粒粒徑小於等於35μm。 The above technical problem to be solved by the present invention is achieved by the following technical solutions: The invention provides a Sanqi broken wall preparation, which adopts the following technical scheme: the smashing of the Sanqi is carried out to obtain an ultrafine powder, and the ethanol-water solution is fully added. Mixing, preparing soft material, further extruding to obtain wet granules, drying to obtain a broken saponin preparation, the ultra-fine powder has a wall breaking rate of 80 to 95%; 90% or more of the ultrafine powder The particle size is 35 μm or less.

較佳地,該超細粉體的破壁率可為80~95%。 Preferably, the ultrafine powder has a wall breaking rate of 80 to 95%.

本發明製備的三七破壁製劑,可以使消費者在服用時不經煎煮,通過用溫開水沖服即可使得有效成分的利用最大化。 The Sanqi broken wall preparation prepared by the invention can make the consumption of the active ingredient maximized by the consumer without decocting by washing with warm boiled water.

可以將三七先粉碎至100目,再進一步進行超微粉碎,使得超細粉體中90%或以上(比如可以是90%、91%、92%、93%、94%或95%)的顆粒粒徑小於等於35μm。本發明方案中採用的超細粉體,90%的顆粒粒徑將近為35μm的粉體,較佳為28~35μm(例如可以為28、29、30、31、32、33、34或35μm)。但本領域人員可以清楚認識的是這些實施例不能作為本發明的限制,只要粒徑小於等於35μm均可實現本發明。 It is possible to pulverize Panax notoginseng to 100 mesh and further carry out ultrafine pulverization so that 90% or more of the ultrafine powder (for example, it may be 90%, 91%, 92%, 93%, 94% or 95%) The particle diameter is 35 μm or less. The ultrafine powder used in the solution of the present invention, 90% of the particles having a particle size of nearly 35 μm, preferably 28 to 35 μm (for example, 28, 29, 30, 31, 32, 33, 34 or 35 μm) . However, it will be apparent to those skilled in the art that these examples are not intended to be limiting of the present invention, and the present invention can be carried out as long as the particle diameter is 35 μm or less.

本發明採用乙醇-水溶液進行濕法製粒,其突出的優點在於不需要任何其他添加劑,即可使得本發明的超細粉體通過後續的製粒、乾燥,成為三七製劑顆粒。但在該過程中,應該採用何種濃度的乙醇-水溶液,以及該溶液與超細粉體之間的配比,都是需要嚴格控制的參數,以使得軟材的濕度、固含量、粘度等可適用於三七超細粉體的特性,使超細粉體之間可有效粘結;進一步通過特定的擠壓參數的設定,將軟材擠壓成為密度、大小合適的三七顆粒製劑,使其密度/蓬鬆度適當,由此在乾燥成為成品之後,即使放置於室溫空氣中,也可以防止空氣的氧化作用。並且,所獲得的成品,在用溫開水沖服時,超細製劑可以較為迅速地散開,使得有效成分迅速而充分地溶解和擴散,提高有效成分利用率。 The present invention employs an ethanol-water solution for wet granulation, which has the outstanding advantage that the ultrafine powder of the present invention can be subjected to subsequent granulation and drying to form trichome granules without any other additives. However, in the process, what concentration of ethanol-water solution should be used, and the ratio between the solution and the ultrafine powder are parameters that need to be strictly controlled to make the moisture, solid content, viscosity, etc. of the soft material. It can be applied to the characteristics of the ultra-fine powder of Panax notoginseng, so that the ultra-fine powder can be effectively bonded; further, through the setting of specific extrusion parameters, the soft material is extruded into the Sanqi granule preparation with appropriate density and size. The density/fluffiness is made appropriate, whereby the oxidation of the air can be prevented even after being dried in the air at room temperature after being dried. Moreover, when the finished product obtained is washed with warm water, the ultrafine preparation can be dispersed relatively quickly, so that the active ingredient dissolves and diffuses rapidly and fully, and the utilization ratio of the active ingredient is improved.

本發明通過多次摸索,最終選取了如下的方案:濕法製粒時,所採用的乙醇-水溶液中乙醇的質量百分比為30%~90%;較佳地,乙醇的質量百分比為40%~80%,更佳地為50%~75%。當乙醇質量百分比為30%~39%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~0.45,較佳為1:0.4;當乙醇質量百分比為40%~49%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~0.45,較佳為1:0.45;當乙醇質量百分比為50%~59%時,超 細粉體與乙醇-水溶液比按重量計為1:0.4~0.6,較佳為1:0.4~0.5;當乙醇質量百分比為60%~69%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~0.7,較佳為1:0.5~0.7;當乙醇質量百分比為70%~79%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~0.8,較佳為1:0.6~0.8;當乙醇質量百分比為80%~90%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~1.0,較佳為1:0.6~0.9。 The invention has repeatedly selected the following schemes: in the wet granulation, the mass percentage of ethanol in the ethanol-water solution used is 30% to 90%; preferably, the mass percentage of ethanol is 40% to 80%. %, more preferably 50% to 75%. When the mass percentage of ethanol is 30% to 39%, the ratio of the ultrafine powder to the ethanol-water solution is 1:0.4 to 0.45 by weight, preferably 1:0.4; when the mass percentage of ethanol is 40% to 49%, The ratio of ultrafine powder to ethanol-water solution is 1:0.4~0.45, preferably 1:0.45; when the mass percentage of ethanol is 50%~59%, super The ratio of fine powder to ethanol-water solution is 1:0.4~0.6, preferably 1:0.4~0.5; when the mass percentage of ethanol is 60%~69%, the ratio of ultrafine powder to ethanol-water solution is by weight. The ratio is 1:0.4~0.7, preferably 1:0.5~0.7; when the mass percentage of ethanol is 70%~79%, the ratio of ultrafine powder to ethanol-water solution is 1:0.4~0.8 by weight, preferably It is 1:0.6~0.8; when the mass percentage of ethanol is 80%~90%, the ratio of ultrafine powder to ethanol-water solution is 1:0.4~1.0, preferably 1:0.6~0.9 by weight.

在將軟材擠壓成為濕粒時,較佳控制在以下條件:採用預裝10目~30目篩網,擠壓力度0.05Mpa~1Mpa,轉速50r/min~100r/min;較佳地,擠壓力度0.75Mpa~0.85Mpa,轉速65r/min~75r/min。 When the soft material is extruded into wet granules, it is preferably controlled under the following conditions: a pre-assembled 10 mesh to 30 mesh screen, a pressing force of 0.05 MPa to 1 MPa, and a rotational speed of 50 r/min to 100 r/min; preferably, The pressing force is 0.75Mpa~0.85Mpa, and the rotation speed is 65r/min~75r/min.

擠壓所得的濕粒粒徑為20目~40目,乾燥時乾燥溫度為45℃~85℃,乾燥時間為0.5小時~2.5小時。 The wet particle size obtained by extrusion is 20 mesh to 40 mesh, the drying temperature during drying is 45 ° C to 85 ° C, and the drying time is 0.5 hour to 2.5 hours.

所獲得的三七破壁製劑的密度為0.35g/ml~0.75g/ml。 The obtained Sanqi broken wall preparation has a density of 0.35 g/ml to 0.75 g/ml.

與現有技術相比,本發明具有以下有益效果:(1)通過本發明的方法獲得的三七製劑,其有效成分利用率大大提高,利用率接近於100%;經生物等效試驗證實,採用1/4份的三七破壁製劑即可相當於1份傳統三七的藥效;(2)本發明通過摸索獲得合適的濕法製粒工藝,使得製粒過程除了乙醇-水的加入之外,沒有引入其他任何添加劑,即可獲得固含量、粘度適中的軟材,以順利地進行擠壓成粒工藝,所形成的中藥顆粒穩定性強,貯存及運輸過程中不易崩爛;(3)本發明的擠壓條件摸索了合適的轉速和擠壓力,由此製成黏性、密度適中的三七顆粒製劑,在獲得成品穩定性強的同時,服用過程中又使其容 易崩解分散,便於溫開水沖服;(4)本發明所述的三七破壁製劑在水中溶散均勻,克服了現有技術中將超細粉體製成製劑後用水溶散出現上部溶液稀下部溶液濃的問題,且有效成分基本均已溶出稱為溶液,不會存在於藥渣粉中,簡單沖服即可獲得良好的藥效。 Compared with the prior art, the present invention has the following beneficial effects: (1) The Sanqi preparation obtained by the method of the invention has greatly improved utilization rate of active ingredients, and the utilization rate is close to 100%; confirmed by bioequivalence test, adopted 1/4 part of the Sanqi broken wall preparation can be equivalent to 1 part of the traditional Sanqi effect; (2) The invention obtains a suitable wet granulation process by groping, so that the granulation process is not only the addition of ethanol-water Without any other additives, the soft material with moderate solid content and moderate viscosity can be obtained to smoothly carry out the extrusion granulation process, and the formed Chinese medicinal particles have strong stability and are not easy to collapse during storage and transportation; (3) The extrusion condition of the invention explores the appropriate rotation speed and the pressing force, thereby preparing the Sanqi granule preparation with moderate viscosity and moderate density, and at the same time obtaining the stability of the finished product, the volume is made during the taking process. It is easy to disintegrate and disperse, and is convenient for warm boiled water; (4) The Sanqi broken wall preparation of the invention dissolves uniformly in water, and overcomes the prior art, the ultrafine powder is prepared into a preparation, and the upper solution is diluted with water. The problem of the lower concentration of the solution, and the active ingredients are basically dissolved out as a solution, which does not exist in the dregs powder, and a good medicinal effect can be obtained by simply blunting.

為了能夠更清楚地理解本發明的技術內容,特舉以下實施例詳細說明,但本發明的實施方式不限於此。 In order to more clearly understand the technical content of the present invention, the following embodiments are specifically described, but the embodiments of the present invention are not limited thereto.

實施例1 Example 1

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶液(乙醇質量百分比為30%)濕法製軟材,溶液與超細粉體加入量比0.4:1(按重量計),混勻後,經預裝10目篩,選用擠壓轉速50r/min,擠壓力度1MPa製濕顆粒,濕顆粒轉置熱風迴圈烘箱中,設定乾燥溫度85℃,乾燥2.5小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh. After ultrafine pulverization into 90% of the ultrafine powder, the powder with a particle size of 35 μm or less is added to the ethanol-water solution (the mass percentage of ethanol is 30). %) Wet process soft material, the ratio of solution to ultrafine powder is 0.4:1 (by weight), after mixing, pre-loaded with 10 mesh sieve, the extrusion speed is 50r/min, and the extrusion strength is 1MPa. The granules and wet granules are transferred into a hot air loop oven, set to a drying temperature of 85 ° C, dried for 2.5 hours to dryness, and the whole granules are sieved to obtain a Sanqi broken wall preparation.

實施例2 Example 2

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶液(乙 醇質量百分比為50%)濕法製軟材,溶液與超細粉體加入量比0.5:1(按重量計),混勻後,經預裝10目篩,選用擠壓轉速60r/min,擠壓力度0.8MPa製濕顆粒,濕顆粒轉置真空微波乾燥箱中,設定乾燥溫度45℃,乾燥0.75小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to about 100 mesh coarse powder, then superfinely pulverize into 90% of the ultrafine powder with a particle size of 35 μm or less, and add ethanol-water solution (B The mass percentage of alcohol is 50%). The wet process is made of soft material. The ratio of solution to ultrafine powder is 0.5:1 (by weight). After mixing, pre-loaded with 10 mesh sieve, the extrusion speed is 60r/min. Wet granules with a pressure of 0.8 MPa, wet granules were transferred into a vacuum microwave oven, set to a drying temperature of 45 ° C, dried for 0.75 hours to dryness, and the whole granules were sieved to obtain a Sanqi broken wall preparation.

實施例3 Example 3

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶液(乙醇質量百分比為90%)濕法製軟材,溶液與超細粉體加入量比0.8:1(按重量計),混勻後,經預裝30目篩,選用擠壓轉速80r/min,擠壓力度0.3MPa製濕顆粒,濕顆粒轉置熱風迴圈烘箱中,設定乾燥溫度85℃,乾燥2.5小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, then ultrafinely pulverize into 90% of the ultrafine powder with a particle size of 35 μm or less, and add an ethanol-water solution (the mass percentage of ethanol is 90). %) Wet method soft material, the ratio of solution to ultrafine powder is 0.8:1 (by weight), after mixing, pre-assembled 30 mesh sieve, using extrusion speed 80r/min, extrusion force 0.3MPa Wet granules, wet granules are transferred into a hot air loop oven, set to a drying temperature of 85 ° C, dried for 2.5 hours to dry, and the whole granules are sieved to obtain a Sanqi broken wall preparation.

實施例4 Example 4

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶液(乙 醇質量百分比為80%)濕法製軟材,溶液與超細粉體加入量比0.8:1(按重量計),混勻後,經預裝30目篩,選用擠壓轉速60r/min,擠壓力度0.5MPa製濕顆粒,濕顆粒轉置真空微波乾燥箱中,設定乾燥溫度50℃,乾燥0.5小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to about 100 mesh coarse powder, then superfinely pulverize into 90% of the ultrafine powder with a particle size of 35 μm or less, and add ethanol-water solution (B The mass percentage of alcohol is 80%). The wet process is made of soft material. The ratio of solution to ultrafine powder is 0.8:1 (by weight). After mixing, pre-loaded with 30 mesh sieve, and the extrusion speed is 60r/min. Wet granules with a pressure of 0.5 MPa, wet granules were transferred into a vacuum microwave oven, set to a drying temperature of 50 ° C, dried for 0.5 hours to dryness, and the whole granules were sieved to obtain a Sanqi broken wall preparation.

實施例5 Example 5

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶液(乙醇質量百分比為75%)濕法製軟材,溶液與超細粉體加入量比0.5:1(按重量計),混勻後,經預裝20目篩,選用擠壓轉速100r/min,擠壓力度0.05MPa製濕顆粒,濕顆粒轉置熱風迴圈風箱中,設定乾燥溫度85℃,乾燥2.0小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to about 100 mesh coarse powder, then pulverize it into ultrafine powder to 90% of the powder with particle size less than or equal to 35μm, and add ethanol-water solution (ethanol mass percentage is 75%) Wet process soft material, the ratio of solution to ultrafine powder is 0.5:1 (by weight), after mixing, pre-installed 20 mesh sieve, select extrusion speed 100r/min, extrusion force 0.05MPa Wet granules, wet granules are transferred into the hot air circulation bellows, set the drying temperature to 85 ° C, dry for 2.0 hours to dry, and the whole granules are sieved to obtain the Sanqi broken wall preparation.

實施例6 Example 6

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶 液的質量百分比為40%的溶液濕法製軟材,溶液與超細粉體加入量比0.45:1(按重量計),混勻後,經預裝20目篩,選用擠壓轉速50r/min,擠壓力度0.2MPa製濕顆粒,採用沸騰乾燥,設定乾燥進風溫度85℃,乾燥1.0小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, and then pulverize it into ultrafine powder to 90% of the powder with a particle size of 35 μm or less, and add ethanol-water soluble solution. The mass percentage of the liquid is 40% of the solution wet-process soft material, the ratio of the solution to the ultra-fine powder is 0.45:1 (by weight), and after mixing, the pre-packed 20 mesh sieve is used, and the extrusion speed is 50r/min. The wet granules with a pressing force of 0.2 MPa are used for boiling drying, and the dry air inlet temperature is set to 85 ° C, dried for 1.0 hour to dryness, and the whole granules are sieved to obtain the Sanqi broken wall preparation.

實施例7 Example 7

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶液(乙醇質量百分比為65%)濕法製軟材,溶液與超細粉體加入量比0.6:1(按重量計),混勻後,經預裝20目篩,選用擠壓轉速70r/min,擠壓力度0.75MPa製濕顆粒,濕顆粒轉置熱風迴圈風箱中,設定乾燥溫度85℃,乾燥2.0小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to about 100 mesh coarse powder, then pulverize it into ultrafine powder to 90% of the powder with particle size less than or equal to 35μm, and add ethanol-water solution (ethanol mass percentage is 65%) Wet process soft material, the ratio of solution to ultrafine powder is 0.6:1 (by weight). After mixing, pre-loaded with 20 mesh sieve, the extrusion speed is 70r/min, and the extrusion force is 0.75MPa. Wet granules, wet granules are transferred into the hot air circulation bellows, set the drying temperature to 85 ° C, dry for 2.0 hours to dry, and the whole granules are sieved to obtain the Sanqi broken wall preparation.

實施例8 Example 8

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶 液(質量百分比為40%)溶液濕法製軟材,溶液與超細粉體加入量比0.6:1(按重量計),混勻後,經預裝14目篩,選用擠壓轉速50r/min,擠壓力度0.8MPa製濕顆粒,採用沸騰乾燥,設定乾燥進風溫度85℃,乾燥1.0小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, and then pulverize it into ultrafine powder to 90% of the powder with a particle size of 35 μm or less, and add ethanol-water soluble solution. The liquid (40% by mass) solution is made into a wet material, and the ratio of the solution to the ultrafine powder is 0.6:1 (by weight). After mixing, the pre-packed 14 mesh sieve is used, and the extrusion speed is 50r/min. The wet granules with a pressing force of 0.8 MPa are used for boiling drying, and the dry air inlet temperature is set to 85 ° C, dried for 1.0 hour to dryness, and the whole granules are sieved to obtain a Sanqi broken wall preparation.

實施例9 Example 9

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶液(乙醇質量百分比為90%)濕法製軟材,溶液與超細粉體加入量比1.0:1(按重量計),混勻後,經預裝30目篩,選用擠壓轉速80r/min,擠壓力度0.9MPa製濕顆粒,濕顆粒轉置熱風迴圈烘箱中,設定乾燥溫度85℃,乾燥2.5小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, then ultrafinely pulverize into 90% of the ultrafine powder with a particle size of 35 μm or less, and add an ethanol-water solution (the mass percentage of ethanol is 90). %) Wet process soft material, the ratio of solution to ultrafine powder is 1.0:1 (by weight), after mixing, pre-assembled 30 mesh sieve, using extrusion speed 80r/min, extrusion force 0.9MPa Wet granules, wet granules are transferred into a hot air loop oven, set to a drying temperature of 85 ° C, dried for 2.5 hours to dry, and the whole granules are sieved to obtain a Sanqi broken wall preparation.

實施例10 Example 10

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶 液(乙醇質量百分比為70%)濕法製軟材,溶液與超細粉體加入量比0.7:1(按重量計),混勻後,經預裝20目篩,選用擠壓轉速90r/min,擠壓力度0.6MPa製濕顆粒,濕顆粒轉置熱風迴圈風箱中,設定乾燥溫度85℃,乾燥2.0小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, and then pulverize it into ultrafine powder to 90% of the powder with a particle size of 35 μm or less, and add ethanol-water soluble solution. The liquid (70% by mass of ethanol) is made of wet process soft material. The ratio of solution to ultrafine powder is 0.7:1 (by weight). After mixing, pre-loaded with 20 mesh sieve, the extrusion speed is 90r/min. Wet granules with a pressing force of 0.6 MPa, wet particles transferred to a hot air loop wind box, set the drying temperature to 85 ° C, dry for 2.0 hours to dry, and the whole granules are sieved to obtain the Sanqi broken wall preparation.

實施例11 Example 11

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶液(乙醇質量百分比為75%)濕法製軟材,溶液與超細粉體加入量比1.0:1(按重量計),混勻後,經預裝20目篩,選用擠壓轉速70r/min,擠壓力度0.95MPa製濕顆粒,濕顆粒轉置熱風迴圈風箱中,設定乾燥溫度85℃,乾燥2.0小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to about 100 mesh coarse powder, then pulverize it into ultrafine powder to 90% of the powder with particle size less than or equal to 35μm, and add ethanol-water solution (ethanol mass percentage is 75%) Wet process soft material, the ratio of solution to ultrafine powder is 1.0:1 (by weight). After mixing, pre-loaded with 20 mesh sieve, the extrusion speed is 70r/min, and the extrusion force is 0.95MPa. Wet granules, wet granules are transferred into the hot air circulation bellows, set the drying temperature to 85 ° C, dry for 2.0 hours to dry, and the whole granules are sieved to obtain the Sanqi broken wall preparation.

實施例12 Example 12

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶 液(乙醇質量百分比為60%)濕法製軟材,溶液與超細粉體加入量比0.6:1(按重量計),混勻後,經預裝20目篩,選用擠壓轉速105r/min,擠壓力度1.1MPa製濕顆粒,濕顆粒轉置熱風迴圈風箱中,設定乾燥溫度85℃,乾燥2.0小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, and then pulverize it into ultrafine powder to 90% of the powder with a particle size of 35 μm or less, and add ethanol-water soluble solution. The liquid (60% by mass of ethanol) is made of wet process soft material. The ratio of solution to ultrafine powder is 0.6:1 (by weight). After mixing, pre-loaded with 20 mesh sieve, the extrusion speed is 105r/min. The pressing force is 1.1MPa to make wet particles, and the wet particles are transferred into the hot air loop wind box. The drying temperature is set at 85 ° C, dried for 2.0 hours to dry, and the whole grain is sieved to obtain the Sanqi broken wall preparation.

實施例13 Example 13

取三七淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於35μm的粉體,加入乙醇-水溶液(乙醇質量百分比為65%)濕法製軟材,溶液與超細粉體加入量比0.6:1(按重量計),混勻後,經預裝20目篩,選用擠壓轉速45r/min,擠壓力度0.04MPa製濕顆粒,濕顆粒轉置熱風迴圈風箱中,設定乾燥溫度85℃,乾燥2.0小時至乾,整粒篩分後即得三七破壁製劑。 Take the Sanqijing medicinal material and coarsely pulverize it to about 100 mesh coarse powder, then pulverize it into ultrafine powder to 90% of the powder with particle size less than or equal to 35μm, and add ethanol-water solution (ethanol mass percentage is 65%) Wet process soft material, the ratio of solution to ultrafine powder is 0.6:1 (by weight), after mixing, pre-installed 20 mesh sieve, select extrusion speed 45r/min, extrusion force 0.04MPa Wet granules, wet granules are transferred into the hot air circulation bellows, set the drying temperature to 85 ° C, dry for 2.0 hours to dry, and the whole granules are sieved to obtain the Sanqi broken wall preparation.

取實施例1~7項下成品按成品質量標準檢驗,結果均符合中國藥典相關劑型項下規定要求,結果如表1所示。 The finished products of the examples 1 to 7 were tested according to the quality standards of the finished products, and the results were all in accordance with the requirements of the relevant Chinese Pharmacopoeia related dosage forms. The results are shown in Table 1.

表1 Table 1

進一步將實施例1~7項下三七破壁製劑與三七超細粉體、三七常規飲片,以性狀、水分和人參皂苷Rg1、Rb1、R1總量作為評價指標,三者均採用密封塑膠袋封裝後放置在溫度40℃±2℃,相對濕度75%±5%的條件下放置3個月後評價各個製劑穩定性。結果如下表: Further, the first three or seven broken wall preparations of Examples 1 to 7 and the Panax notoginseng ultrafine powder and the Sanqi conventional decoction pieces were used as the evaluation indexes for the traits, water and the total amount of ginsenoside Rg 1 , Rb 1 and R 1 . They were all packaged in a sealed plastic bag and placed at a temperature of 40 ° C ± 2 ° C and a relative humidity of 75% ± 5% for 3 months to evaluate the stability of each formulation. The results are as follows:

以下再一步通過急性毒性、藥效對比實驗說明本發明的先進性,取實施例7製得的三七破壁製劑與傳統飲片比較。 In the following step, the advanced nature of the present invention is illustrated by an acute toxicity and efficacy comparison experiment. The Sanqi broken wall preparation prepared in Example 7 is compared with a conventional decoction piece.

一、急性毒性試驗 First, acute toxicity test

昆明小白鼠40隻,體重18~22克,雌雄各半,隨機分成照組(蒸餾水0.4ml/10g鼠),三七片組、三七剪口組、三七破壁製劑組給予1g/ml濃度的原藥液(為最大濃度)0.4ml/10g鼠。 40 Kunming mice, weighing 18-22 grams, half male and half female, were randomly divided into photo group (distilled water 0.4ml/10g mouse), Sanqi tablet group, Sanqi cut mouth group and Sanqi broken wall preparation group were given 1g/ml. The concentration of the original drug solution (for maximum concentration) 0.4ml/10g mouse.

表2結果表明三七片、三七剪口飲片、三七破壁製劑對小鼠灌胃一日最大給藥量為120g/kg,均無明顯急性毒性產生。 The results in Table 2 indicate that the maximum daily dose of Sanqi Tablet, Sanqi Shekou Decoction Tablet and Sanqi Broken Wall Preparation on mice was 120g/kg, and no significant acute toxicity was observed.

二、藥效學比較 Second, pharmacodynamic comparison

昆明小白鼠56隻,雌雄各半,隨機分為7組,每組8隻。分為正常組(生理鹽水)、三七飲片組(62.5mg/kg)、三七剪口飲片組(62.5mg/kg)、三七破壁製劑等劑量組(62.5mg/kg)、三七破壁製劑低劑量組(7.8mg/kg)、三七破壁製劑中劑量組(15.6mg/kg)、三七破壁製劑高劑量組(31.25mg/kg)。破壁製劑組是將實施例7製得的製劑放置90天之後,以60℃左右的溫開水沖調,取上清液灌胃給藥。 There were 56 Kunming mice, half male and half female, randomly divided into 7 groups, 8 in each group. Divided into normal group (salt saline), Sanqi decoction group (62.5mg/kg), Sanqi Jiankou decoction group (62.5mg/kg), Sanqi broken wall preparation, etc. (62.5mg/kg), Sanqi The low-dose group (7.8mg/kg), the middle dose group (15.6mg/kg), and the high-dose group (31.25mg/kg) of the broken powder of Sanqi. In the broken wall preparation group, the preparation prepared in Example 7 was allowed to stand for 90 days, and then washed with warm water of about 60 ° C, and the supernatant was administered by intragastric administration.

表3結果表明三七破壁製劑的藥效作用優於三七常規飲片、剪口飲片,相當於1/4量。 The results in Table 3 show that the pharmacodynamic effect of the Sanqi broken wall preparation is better than that of the Sanqi conventional decoction pieces and the cut-off pieces, which is equivalent to 1/4 amount.

Claims (9)

一種三七破壁製劑,其係將三七進行破壁粉碎獲得超細粉體,加入乙醇-水溶液製軟材,再進一步擠壓獲得濕粒,乾燥獲得三七破壁製劑;其中該超細粉體中90%或以上的顆粒粒徑小於等於35μm。 A Sanqi broken wall preparation, which is obtained by breaking the wall and pulverizing to obtain ultrafine powder, adding an ethanol-water solution to a soft material, further extruding to obtain a wet granule, and drying to obtain a Sanqi broken wall preparation; wherein the superfine 90% or more of the particles in the powder have a particle diameter of 35 μm or less. 根據申請專利範圍第1項所述的三七破壁製劑,其中該乙醇-水溶液中乙醇的質量百分比為30%~90%。 The Sanqi broken wall preparation according to Item 1 of the patent application, wherein the mass percentage of ethanol in the ethanol-water solution is 30% to 90%. 根據申請專利範圍第1項所述的三七破壁製劑,其中該超細粉體與乙醇-水溶液質量比為1:0.4~1.0。 The Sanqi broken wall preparation according to Item 1 of the patent application, wherein the mass ratio of the ultrafine powder to the ethanol-water solution is 1:0.4 to 1.0. 根據申請專利範圍第1項所述的三七破壁製劑,其中當乙醇質量百分比為30%~39%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~0.45;當乙醇質量百分比為40%~49%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~0.45;當乙醇質量百分比為50%~59%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~0.6;當乙醇質量百分比為60%~69%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~0.7;當乙醇質量百分比為70%~79%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~0.8;當乙醇質量百分比為80%~90%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~1.0。 According to the Sanqi broken wall preparation according to claim 1, wherein when the mass percentage of ethanol is 30% to 39%, the ratio of the ultrafine powder to the ethanol-water solution is 1:0.4 to 0.45 by weight; When the mass percentage is 40%~49%, the ratio of ultrafine powder to ethanol-water solution is 1:0.4~0.45; when the mass percentage of ethanol is 50%~59%, the ratio of ultrafine powder to ethanol-water solution The weight is 1:0.4~0.6; when the mass percentage of ethanol is 60%~69%, the ratio of ultrafine powder to ethanol-water solution is 1:0.4~0.7 by weight; when the mass percentage of ethanol is 70%~79 When %, the ratio of ultrafine powder to ethanol-water solution is 1:0.4~0.8 by weight; when the mass percentage of ethanol is 80%~90%, the ratio of ultrafine powder to ethanol-water solution is 1:0.4 by weight. ~1.0. 根據申請專利範圍第4項所述的三七破壁製劑,其中當乙醇質量百分比為30%~39%時,超細粉體與乙醇-水溶液比按重量計為1:0.4;當乙醇質量百分比為40%~49%時,超細粉體與乙醇-水溶液比按重量計為1:0.45;當乙醇質量百分比為50%~59%時,超細粉體與乙醇-水溶液比按重量計為1:0.4~0.5;當乙醇質量百分比為60%~69%時,超細粉體與乙醇 -水溶液比按重量計為1:0.5~0.7;當乙醇質量百分比為70%~79%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~0.8;當乙醇質量百分比為80%~90%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~0.9。 According to the Sanqi broken wall preparation according to Item 4 of the patent application, wherein when the mass percentage of ethanol is 30% to 39%, the ratio of ultrafine powder to ethanol-water solution is 1:0.4 by weight; when the mass percentage of ethanol is When 40%~49%, the ratio of ultrafine powder to ethanol-water solution is 1:0.45; when the mass percentage of ethanol is 50%~59%, the ratio of ultrafine powder to ethanol-water solution is 1:0.4~0.5; when the mass percentage of ethanol is 60%~69%, ultrafine powder and ethanol - the ratio of aqueous solution is 1:0.5~0.7 by weight; when the mass percentage of ethanol is 70%~79%, the ratio of ultrafine powder to ethanol-water solution is 1:0.6~0.8 by weight; when the mass percentage of ethanol is 80% When the ratio is from % to 90%, the ratio of the ultrafine powder to the ethanol-water solution is 1:0.6 to 0.9 by weight. 根據申請專利範圍第1項所述的三七破壁製劑,其中該三七破壁製劑的堆密度為0.35g/ml~0.75g/ml。 The Sanqi broken wall preparation according to Item 1 of the patent application, wherein the Sanqi broken wall preparation has a bulk density of 0.35 g/ml to 0.75 g/ml. 根據申請專利範圍第1項所述的三七破壁製劑,其中該擠壓的條件為:濕法製粒:預裝篩網目數為10目~30目,擠壓力度0.05Mpa~1Mpa,轉速50r/min~100r/min。 According to the Sanqi broken wall preparation described in the first paragraph of the patent application scope, the extrusion conditions are: wet granulation: the pre-loaded sieve mesh number is 10 mesh to 30 mesh, the pressing force is 0.05 Mpa~1 Mpa, and the rotational speed is 50 r. /min~100r/min. 根據申請專利範圍第7項所述的三七破壁製劑,其中該擠壓的條件為:濕法製粒:擠壓力度0.75Mpa~0.85Mpa,轉速65r/min~75r/min。 According to the Sanqi broken wall preparation described in Item 7 of the patent application, the extrusion conditions are: wet granulation: extrusion force 0.75Mpa~0.85Mpa, rotation speed 65r/min~75r/min. 根據申請專利範圍第1項所述的三七破壁製劑,其中該擠壓所得的濕粒粒徑為20目~40目,乾燥時乾燥溫度為45℃~85℃,乾燥時間為0.5小時~2.5小時。 According to the Sanqi broken wall preparation described in the first paragraph of the patent application, wherein the wet particle size obtained by the extrusion is 20 mesh to 40 mesh, the drying temperature during drying is 45 ° C to 85 ° C, and the drying time is 0.5 hour. 2.5 hours.
TW103110366A 2013-03-20 2014-03-19 Panax notoginseng broken wall preparation TWI549700B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310089870.6A CN104055813B (en) 2013-03-20 2013-03-20 A kind of Radix Notoginseng broken wall preparation

Publications (2)

Publication Number Publication Date
TW201436822A true TW201436822A (en) 2014-10-01
TWI549700B TWI549700B (en) 2016-09-21

Family

ID=51543932

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103110366A TWI549700B (en) 2013-03-20 2014-03-19 Panax notoginseng broken wall preparation

Country Status (3)

Country Link
CN (1) CN104055813B (en)
HK (1) HK1201158A1 (en)
TW (1) TWI549700B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105998181A (en) * 2016-07-13 2016-10-12 顾世民 Decoction pieces with controllable content of active substances mainly including fresh notoginseng and radix salvia miltiorrhiza and preparation preparing method

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106265802A (en) * 2016-08-08 2017-01-04 湖南盟合投资管理有限公司 The preparation method of Radix Notoginseng breaking cellular wall decoction pieces
CN108310030A (en) * 2018-03-19 2018-07-24 上海健康医学院 A kind of nanometer of broken wall Radix Notoginseng powder capsule and preparation method thereof
CN108653343A (en) * 2018-07-27 2018-10-16 萃博士(平潭)生物科技有限公司 It is a kind of for anticancer, liver protection Antrodia camphorata extract preparation method
CN114563533A (en) * 2022-03-02 2022-05-31 云南现代民族药工程技术研究中心 Method for detecting exogenous pollutants of panax notoginseng

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1355018A (en) * 2000-11-23 2002-06-26 武汉莱奇尔中药现代化研究开发有限公司 Process for preparing micron-class of Chinese-medicinal material
CN101147746B (en) * 2006-09-18 2011-02-16 中山市中智药业集团有限公司 Method for processing traditional Chinese herbs broken wall powder
CN101850066B (en) * 2009-11-06 2012-02-08 中山市中智中药饮片有限公司 Chinese medicinal composition granules and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105998181A (en) * 2016-07-13 2016-10-12 顾世民 Decoction pieces with controllable content of active substances mainly including fresh notoginseng and radix salvia miltiorrhiza and preparation preparing method
CN105998181B (en) * 2016-07-13 2017-08-01 顾世民 The controllable medicine materical crude slice preparation method of activity substance content based on fresh pseudo-ginseng, the red sage root

Also Published As

Publication number Publication date
CN104055813B (en) 2018-07-17
HK1201158A1 (en) 2015-08-28
TWI549700B (en) 2016-09-21
CN104055813A (en) 2014-09-24

Similar Documents

Publication Publication Date Title
TWI549700B (en) Panax notoginseng broken wall preparation
TWI531387B (en) A preparation method of astragalus breaking preparation
TWI566785B (en) A preparation method of Dendrobium broken
TWI530302B (en) A method for preparing salvia miltiorrhiza and its preparation
CN1785336A (en) Tongyou dryness moistening fast dispersion solid preparation and its preparation method
TWI508752B (en) A preparation method of chrysanthemum broken wall preparation
CN1785368A (en) Lingyang lung clearing fast dispersion solid preparation and its preparation method
CN100515471C (en) Liver kidney nourishing fast dispersion solid preparation and its preparation method
CN104055814B (en) A kind of preparation method of American Ginseng broken wall preparation
CN100384405C (en) Hepatitis B support right fast dispersion solid preparation and its preparation method
TWI501787B (en) A preparation method of American ginseng broken wall preparation
CN104055825B (en) A kind of Radix Codonopsis broken wall preparation
CN103099803A (en) Method for solubilization and synchronous dissolution of bilobalide
CN103099825B (en) Novel cordyceps sinensis capsule and preparation method thereof
CN1785398A (en) Kunshun fast dispersion solid preparation and its preparation method
CN100384402C (en) Jinsang sanjie fast dispersion solid preparation for treating throat and its preparation method
CN1785300A (en) Zuojin fast dispersion solid medicine and its preparation method
CN104055815B (en) A kind of red ginseng broken wall preparation
CN100515406C (en) Macaque stone bovinebezoar fast dispersion solid preparation and its preparation method
CN100515411C (en) Fast dispersion solid preparation for Child and its preparation method
CN1785369A (en) Kunbao (female treasure) fast dispersion solid preparation and its preparation method
CN104055809B (en) A kind of Radix Angelicae Sinensis broken wall preparation
CN1785305A (en) Flowery knotwood root fast dispersion solid medicine and its preparation method
CN100486564C (en) Jinkui kidney qi fast dispersion solid preparation and its preparation method
CN104800332A (en) Menstruation regulating beautifying tablet and preparation method thereof